- Home
- / IGM Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
IGM Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$17.3
2024-10-29
Market Capitalization
$1 B
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 2.5M | 3.8M | 9.2M | 18.3M | 38.3M | 49.7M | 50.1M | 50.4M |
| Operating expense total | 11.1M | 22.8M | 44.5M | 83.3M | 229.0M | 211.3M | ||
| EBIT | (11.1M) | (22.8M) | (44.5M) | (83.3M) | (165.3M) | (228.0M) | (263.5M) | (208.6M) |
| Interest expense | 7.0M | 17.7M | 12.8M | |||||
| Pre tax profit | (245.7M) | (195.8M) | ||||||
| Income tax expense | 678.0K | |||||||
| Net Income | (11.1M) | (22.7M) | (43.1M) | (81.4M) | (165.2M) | (221.1M) | (246.4M) | (195.8M) |
| EPS | (5.3) | (4.0) | (3.2) |